US20040147978A1 - Electro stimulation treatment apparatus and method - Google Patents

Electro stimulation treatment apparatus and method Download PDF

Info

Publication number
US20040147978A1
US20040147978A1 US10/734,925 US73492503A US2004147978A1 US 20040147978 A1 US20040147978 A1 US 20040147978A1 US 73492503 A US73492503 A US 73492503A US 2004147978 A1 US2004147978 A1 US 2004147978A1
Authority
US
United States
Prior art keywords
subject
probes
electrical
return
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/734,925
Other languages
English (en)
Inventor
Axel Bernhard
Alan Cook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SKOP GmbH Ltd
Original Assignee
SKOP GmbH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SKOP GmbH Ltd filed Critical SKOP GmbH Ltd
Assigned to SKOP GMBH LTD reassignment SKOP GMBH LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BERNHARD, AXEL L., COOK, ALAN
Publication of US20040147978A1 publication Critical patent/US20040147978A1/en
Priority to US13/565,849 priority Critical patent/US9572978B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems
    • A61N1/36034—Control systems specified by the stimulation parameters

Definitions

  • the invention relates generally to a method and apparatus for electro stimulation treatment of the body, cells or tissue cultures wherein electrical power is applied to a plurality of probes that are in electrical connection with the subject of the treatment.
  • the invention is particularly suited to the treatment of any areas or areas of the body with electrical currents for cosmetic and/or medical purposes that currently require a relatively high level of manual intervention and operation by a skilled operator.
  • Electro stimulation apparatus that provides micro current treatments gained popularity in the mid 1980's.
  • the advent of electro stimulation treatment apparatus provided medical and cosmetic benefits although they required a relatively high level of intervention by operators providing long periods of “hands on” treatments.
  • clients/patients herein referred to as subject
  • Non-uniform exposure of an area requiring treatment will usually result in reduced efficacy of the treatment.
  • a subject may require more treatments than necessary to achieve the result they require and hence will necessarily be required to devote more time to receiving treatments than would otherwise be required.
  • the present invention provides an electro stimulation system for providing signals to a subject including:
  • At least one electrical power supply At least one electrical power supply
  • a first switching device for intermittently connecting the output of an electrical power supply to one or more connection probes electrically connected to the subject
  • a second switching device for intermittently connecting one or more connection probes electrically connected to the subject to form an electrical current return path for current supplied by the electrical power supply;
  • switching control devices connected to the first and second switching devices
  • the output of an electrical power supply is connected to a current control circuit such that electrical current supplied to the subject is regulated or controlled.
  • the switching device is a multiplexing device connected to a multiplexing control device.
  • the first and second switching devices may be realised as separate units or may both reside within a single unit or apparatus such as an integrated circuit. Further, the first and second switching devices may be separate from the one or more electrical power supplies or may reside within a single housing along with the one or more supplies.
  • the arrangement of “active” probes and “return” probes primarily determines the path of electrical current flow through an area to be treated.
  • the determination of the probes as either “active” or “return” type probes is determined by the multiplexing control device.
  • each probe is connected to a first multiplexing device with the connection to the probe configured as an output of the device.
  • each probe is also connected to a second multiplexing device with the connection to the probe configures as an input to the device.
  • the first multiplexing device connects one or more probes to the output of the current control circuitry whilst the second multiplexing device connects one or more probes to an electrical current return path.
  • a probe should only be either an active or return type probe at any one time. Connection of the outputs of the multiplexing devices allows any particular probe to be switched many times between the two types (i.e. active or return) during a treatment but any individual probe should not be selected as an active probe (i.e. connected to the output of the current control circuitry through the first multiplexer) at the same time that it is selected as a return probe (i.e. connected to the return path through the second multiplexer).
  • connection arrangement of probes and the ability to control the type of the probe at any particular time during a treatment enables the provision of complex electrical current distributions amongst a set of probes connected to an area for treatment.
  • the present invention provides a controlled electrical signal supply for supplying electrical currents to a subject, said electrical current flowing through an area of the subject by connection of same with at least one active and return probe wherein,
  • an electrical power supply is connected to the at least one active probe
  • a first electrical resistance is connected in parallel with the active and return probe
  • the junction between the probe and the first resistance is connected to a ground reference through a controllable variable conductance network.
  • the first electrical resistance is preferably chosen to be significantly greater than the expected resistance presented between active and return probes in the area of the subject.
  • the connection of a first resistance in parallel with the active and return probes substantially reduces the incidence of a stinging sensation when active probes are first attached to a treatment area.
  • the choice of a significantly greater resistance as compared with the inter probe resistance of a treatment area also ensures that the majority of electrical current from a power supply passes through the area being treated.
  • the junction between the return probe and the first resistance is connected to a ground reference through a controlled variable conductance network.
  • controlling the conductance of the network substantially controls the amount of electrical current flowing through the area under treatment.
  • variable conductance network includes a conductance path formed by a collector-emitter path through a transistor in series connection with a second electrical resistance.
  • control signal network includes an operational amplifier receiving one input from the conductance network connected to the junction of the emitter and the second resistance and a second input from a digital to analogue converter (DAC).
  • the operational amplifier is preferably configured as a differential amplifier with the input from the DAC connected to the non-inverting input and the output from the conductance network, providing a voltage proportional to the electrical current flowing through the area under treatment, connected to the inverting input.
  • the voltage signal output from the DAC represents the electrical current that will flow through the area under treatment.
  • This particular current flow will be maintained by the controlled variable conductance network to accommodate any changes to the conductance presented between the active and return probe by the area under treatment thus ensuring that the electrical current flowing between active and return probes is maintained at the value represented by the output voltage of the DAC.
  • the output voltage of the DAC is controlled by a digital output of a microprocessor, which may be programmed to provide a varying DAC output voltage, thus causing a similarly varying electrical current flow through an area under treatment.
  • Microprocessor control of the current flow through a treatment subject enables the establishment of treatments that include complex electrical current waveforms that will flow between active and return probes.
  • the speed of the control loop of the controlled variable conductance network is only limited by the speed of the devices forming the network producing the error, or difference, signal that is input to the base of the transistor, thus controlling the conductance of the variable conductance network.
  • the present invention provides a method of providing electro stimulation to a subject including the steps of:
  • the selection of active and return probes is varied throughout the treatment and in one preferred embodiment, only a single probe is active at any one time whilst only a single probes is also selected as return probe.
  • the selection and connection of active and return probes in method steps d) and e) are chosen such that during any period of substantially zero current flow in one area of treatment, current flow is established in another area of treatment.
  • the present invention provides a method of controlling the supply of an electrical current to a subject connected to an electrical power supply unit that is in electrical connection with an area of the subject by at least one active probe and return probe respectively including a first electrical resistance connected in parallel with the at least one active and return probe and having a controllable variable conductance network connected between the junction of the return probe and the first resistance and a ground reference, the method including the following steps:
  • variable conductance network Initially controlling the variable conductance network to present a low conductance such that limited current can flow through the area of the subject;
  • a predetermined probe arrangement for a particular part of the body incorporated in a piece of material that may be placed over the area requiring treatment such that the probes are placed in connection with the treatment subject at approximately the required locations.
  • the material may be elasticised and formed in the shape of the area requiring treatment for ease of location on the subject.
  • a pre-determined probe arrangement for a foot may be incorporated into an elasticised piece of material in the shape of a sock, thus enabling the subject to easily place the sock on the foot and hence locate all the probes reasonably accurately for a treatment of the subject's foot.
  • pre-determined probe arrangements for all parts of a subject's body may be established and in the instance of facial treatments, a mask incorporating an arrangement of probes may be placed on the face of a subject thus locating all the probes quickly and easily prior to commencement of an electro stimulation treatment.
  • a body suit of suitable material incorporating pre-determined probe arrangements allows for quick and relatively accurate placement of a large number of probes.
  • a probe should only be either an active probe or a return probe. However, for calibration of the apparatus, a probe may be selected as an active probe and a return probe simultaneously.
  • the term probe is intended to include any apparatus capable of providing an electrical connection to the subject of a treatment.
  • the connection could be as a result of direct contact with, or penetration into, the treatment subject or indirect contact by means of an electrolytic solution.
  • the electrical connection could be implemented without any contact such as an inductive connection.
  • the provision of electro stimulation signals is described with reference to the treatment of a subject.
  • the term “pad” is used which refers to a probe that is attached to the skin tissue to form an electrical connection therewith. Pads are generally secured to subjects for this form of treatment by some form of adhesive or elastic bands.
  • FIG. 1 is a circuit diagram of two separate power supplies and respective current control circuits for the regulation of current supply to the skin tissue of a subject;
  • FIG. 2 is a circuit diagram of four separate multiplexing devices
  • FIG. 3 is a circuit diagram of a microprocessor and a digital to analogue converter
  • FIG. 4 is a circuit diagram of a display that is connected to the microprocessor of FIG. 3;
  • FIG. 5 is a circuit diagram of a conventional power supply arrangement for supplying power to the devices in FIGS. 1 to 4 ;
  • FIGS. 6A to 6 D detail four example electrical current signal patterns between various pads of an eight pad configuration
  • FIGS. 7A and 7B detail example electrical current signal patterns between various pads in an embodiment of the invention that includes a plurality of power signals applied to the skin tissue of a patent;
  • FIGS. 8A and 8B detail a standard waveform and a split cycle waveform respectively.
  • FIG. 9 details an example electrical current signal pattern for two separate areas under treatment using a split cycle approach to effectively treat both areas simultaneously.
  • This scheme leads to superior signal control, and thus more efficient treatment of a subject, and also greatly enhances the ability to effectively switch signals between multiple sources and destinations.
  • high absolute voltages are maintained on the tissue, which promote improved current flow.
  • the WCV allows complex current waveforms to be generated in the skin tissue. By varying the WCV signal in a specified and preferred pattern, the current between a CRE and a PSE will match this waveform.
  • HVMUX high voltage multiplexer integrated circuit
  • the HVMUX is an 8:1 configuration. This means that any one of 8 input signals can be selectively switched to one output signal. Alternatively, one input signal can be selectively switched to one of 8 output signals (eg any one of eight pads can be selected as an active pad for the supply of an electrical signal to skin tissue). Return pads may be selected in the same way. Of course, there are variations of this arrangement, including 2 ⁇ 4:1, 16:1 etc.
  • any of the preferred embodiments of the invention that has more than a single CR is capable of generating different current waveforms, by applying different WCV signals to them. The effect of this is to generate more complex waveforms in the tissue than the simple waveforms defined by the WCVs.
  • Each WCV is created wholly independently of the others by a microprocessor circuit (U 1 , FIG. 3).
  • This microprocessor in a preferred embodiment of the invention also controls the user interface to the apparatus.
  • Waveforms may be generated or selected for generation from a variety of sources.
  • a preferred set of waveforms may be pre-stored in the microprocessor, or a list of waveform attributes may be selected by the user from a menu or similar collection of predefined values.
  • the user may be allowed to define the precise waveform characteristics they require, in which case the microprocessor may calculate the relevant parameters of the waveform in real time.
  • a microprocessor controls one or more independent power supplies and an array of multiplexing/switching devices.
  • the power supply provides an electrical signal and a current return.
  • the switching device is capable of switching a signal or a current return to 1 of 8 pins of the multiplexing device.
  • one multiplexing device is used for the switching of the signal and another multiplexing device is used for the switching of current returns to 5 (or more) pins.
  • Either the signal or a current return can be switched to one of the 8 pins first, then the other may be switched to any of the remaining 7 pins.
  • a sophisticated switching pattern may be established to stimulate any tissue within the area effectively by activating up to 20 paths for 5 pads (5 ⁇ 4 possibilities), 30 paths for 6 pads (6 ⁇ 5 possibilities), 42 paths for 7 pads (7 ⁇ 6 possibilities) or 56 paths for 8 pads (8 ⁇ 7 possibilities).
  • a plurality of independent power supplies can be switched via multiple sets of multiplexing devices and stimulate more areas or create more intricate and sophisticated stimulation patterns.
  • Providing a current controlled signal to one pin of the first multiplexing device (U 4 FIG. 2) and a return path to one pin of the second multiplexing device (U 5 FIG. 2) allows the combination of two padded areas into one and an even more sophisticated stimulation pattern. Similarly more power supplies may be switched similarly allowing a much larger number of current paths.
  • circuit arrangement of the invention enables a power supply to generate precise current regulated wave forms for application to the tissue of a subject.
  • a control loop is established that substantially reduces “lag” in the control loop as compared with known systems. More particularly, overcoming “lag” in the control loop and effecting control using current regulation, as opposed to voltage regulation, enables numerous advantages to be realised.
  • An electrical signal is applied to skin tissue via terminals PS 1 and Wave 1 , the signals on these terminals being switched through multiplexers U 4 and U 5 (refer FIG. 2) to probes that are either in direct or indirect contact with the skin tissue of a subject.
  • the skin tissue of a subject is effectively in parallel with the resistor R 40 .
  • the transistor Q 1 is in an active mode, there is a flow of current through R 40 .
  • the voltage appearing at the junction of R 37 and the emitter is applied to the inverting input of the operational amplifier U 10 A.
  • the operational amplifiers in the current regulator circuits are configured as differential amplifiers. Accordingly, the signal on the inverting input is compared to the signal present on the non-inverting input which, in the current regulator circuit being described, is a signal called ISET 1 scaled by the potential divider formed by resistors R 32 and R 33 .
  • the current regulation circuits detailed in FIG. 1 have a very fast control loop wherein the voltage established as ISET 1 causes a current proportional to that voltage to flow through R 40 .
  • the value of R 40 is relatively large in order to prevent current spikes when probes are initially attached to the skin of a subject. Electrical current flows though skin tissue in parallel with the current flow through resistor R 40 and, if there is a substantial difference in the impedance presented by skin tissue (typically under 30 kohms), the current flowing through resistor R 40 can effectively be ignored.
  • the current regulator circuits it is reasonable to consider the current regulator circuits to be measuring the current flow through skin tissue.
  • the impedance presented to the current regulator circuit for example, due to changes in the impedance of skin tissue, the current regulator circuit (immediately) adapts to the change in skin tissue impedance to retain the desired current flowing through the tissue.
  • any voltage signal applied to ISET 1 causes a proportional current to flow through the skin tissue.
  • ISET 1 defines a voltage wave form
  • a proportional current wave form flows through the skin tissue of the subject.
  • the voltage signals ISET 1 and ISET 2 that cause proportional current flow through the skin tissue of a subject are generated by microprocessor U 1 (refer FIG. 3) and by converting a digital representation of a signal value from the microprocessor U 1 through the digital to analogue converter (TLC7226).
  • device DS1994 is a secure accounting device in the form of a secure memory that records the hours of use of the apparatus.
  • the apparatus is provided to therapists for no basic charge and the therapist only pays for time for which the apparatus is used.
  • a therapist pays for a number of hours in advance and the secure accounting device tracks the cumulative time for which the apparatus is used and causes deactivation of the apparatus once the operation time for which the apparatus has been paid expires.
  • the device LCD 1 is an LCD display that is used to provide information to the operator of the apparatus.
  • the display Upon activation of the apparatus, the display indicates to the operator the amount of available time remaining to operate the apparatus before the apparatus is automatically deactivated.
  • the display indicates to operators the treatment that has been selected and the program that has been selected within that particular treatment regime.
  • the display can also indicate the current battery status and any other information relevant to the operational characteristics of the apparatus.
  • the display can also indicate to the operator the amount of time required for that particular treatment and can “count down” the time remaining until cessation of a particular treatment.
  • the display also indicates to the operator the conductivity status of the probes connected to the skin tissue of a subject.
  • this information can assist in advising an operator of potential connectivity problems with respect to the skin tissue probes. For example, in the event that skin tissue probes are disconnected from the skin tissue of a subject during a treatment, the information displayed regarding the conductivity between the probes can advise the operator that this condition has occurred enabling them to take corrective action during the treatment process.
  • the device U 2 and associated circuitry forms a power inverter to convert low DC voltages to an AC voltage of 130 volts for the purpose of providing an LCD backlight power supply for the LCD display.
  • Q 3 , R 23 and R 24 and speaker SPKR 1 provide the apparatus with an audio capability such as sounding a beep in the event that an error condition occurs or to indicate the operation of the user interface.
  • the user input in the preferred embodiment includes 6 push buttons.
  • the function of these buttons varies depending upon the operating mode of the power supply.
  • the microprocessor U 1 stores several tables of data. These tables include the Treatment Table, the Program Table and the Multiplexer Table.
  • the Treatment Table currently includes up to 128 different treatments that can be customised through an editor.
  • a Treatment Table currently includes a list of 16 programs, not all of which need be active. Treatments are selected using one of the push buttons (not detailed). This action scrolls through a list of active treatments, displaying the treatment name on the LCD display. The treatment will revert back to the first enabled treatment after the last enabled treatment.
  • Treatments include a list of individual programs which are normally activated sequentially. However to enable treatments to be started part way through a treatment, one of the buttons allows a program within a treatment to be selected and commenced. Currently a treatment may comprise 16 separate programs.
  • the Program Table includes a list of program parameters. Currently up to 128 programs are may be defined in memory, and may be edited by a built in editor.
  • the microprocessor U 1 In addition to generating the signals ISET 1 and ISET 2 , the microprocessor U 1 also generates control signals for the multiplexing devices U 4 , U 5 , U 7 and U 8 (refer FIG. 2).
  • Device U 9 is a latch that latches eight separate signals from the microprocessor (DD 0 to DD 7 ) upon the application of an enable signal to the latch device U 9 .
  • the supply signal PS 1 is sourced from the power supply comprising device U 3 and associated circuitry (refer FIG. 1).
  • the signal is sourced through resistor R 29 which limits electrical current supplied to the skin tissue of a subject and selection of R 29 can also ensure that the voltage applied to the skin tissue never exceeds a voltage level that could cause damage to the multiplexing devices.
  • the input signal ENHI 1 effectively controls all the output signals of the multiplexing device and, in the instance that the signal ENHI 1 is at a logic low level, there is no power supplied from signal line PS 1 through device U 4 .
  • the power supply PS 1 can be completely disconnected from the skin tissue of a subject.
  • the three input signals HISEL 0 , HISEL 1 and HISEL 2 enables selection of one of the outputs of the multiplexing device to deliver power supply signal PS 1 to the skin tissue of a subject.
  • power supply signal PS 1 can be applied to any one of the output signal lines of the multiplexing device U 4 , namely P 1 _ 1 to P 1 _ 8 .
  • the multiplexing device U 5 may be configured to receive signals from another probe connected to the skin tissue of a subject to form a return current path for electrical current through multiplexing device U 5 and provide that return path as signal Wave 1 to the current regulator circuit (refer FIG. 1).
  • the multiplexing devices U 4 and U 5 have their signal lines IN 1 to IN 8 connected such that upon connection of these individual signal lines to individual pads for application to the skin tissue of a subject, configuration of the multiplexing devices U 4 and U 5 enables the power supply signal PS 1 to be directed to any one of the pads connected to a subject's skin tissue and the establishment of a return current path via any one of the remaining pads.
  • the current invention enables the apparatus to be pre-programmed to apply specific signal patterns between one or more respective probes depending upon the region of the body to be treated.
  • a power supply signal may be applied to one pad connected to the skin tissue of a subject with only one other pad acting as a return path for electrical current thus directing the electrical current signal between two specific pads, namely the power supply pad and the return path pad.
  • the current regulated signal passing through the subject's skin tissue may be redirected through those different pads.
  • the ability of the apparatus of the present invention to provide complex and comprehensive signal coverage to the skin tissue of a subject under treatment is further enhanced when more than one power supply signal is applied to the skin tissue of a subject at one time.
  • three pads providing three respective power supply signals PS 1 , PS 2 and PS 3 is depicted with three respective current return path pads C 1 , C 2 and C 3 .
  • three separate power supply signals, PS 1 , PS 2 and PS 3 are applied to the skin tissue with only a signal current return path C 1 activated.
  • the skin tissue between the pads PS 1 , PS 2 and PS 3 and C 1 is subject to treatment by the current regulated signals PS 1 , PS 2 and PS 3 between the skin tissue to which the pads are connected.
  • the supply signals PS 1 , PS 2 and PS 3 may be supplied sequentially or simultaneously and may even comprise different current wave forms for each of the supply signals.
  • the complexity of signal distribution through the skin tissue resident between pads PS 1 , PS 2 and PS 3 and the return path pads C 1 , C 2 and C 3 is significantly increased when electrical current is passed between pads C 1 and PS 1 , C 2 and PS 1 , C 3 and PS 1 , C 1 and PS 2 , C 2 and PS 2 , C 3 and PS 2 , C 1 and PS 3 , C 2 and PS 3 , C 3 and PS 3 .
  • each program entry in the Program Table defines the following information which is required to generate a waveform:
  • Each table includes 64 single byte entries that define the selection status of the pair of multiplexer chips associated with a single current regulator circuit.
  • a typical waveform is detailed that includes a rising slope of a first half of the waveform 18 , a period of time at the maximum designated current 20 , a falling slope of the first half of the waveform 22 and a period of substantially zero current flow 24 thus completing a waveform cycle.
  • This waveform is substantially repeated at 26 , 28 , 30 and 32 thus producing a waveform of the desired frequency by selection of the periods of time corresponding with 18 , 20 , 22 and 24 .
  • a split cycle arrangement is detailed in FIG. 8B wherein two separate areas requiring treatment are supplied with two current waveforms I, and I 2 .
  • period 34 area 1 is subject to a first half of a waveform 35 whereas area 2 has a substantially zero current flow.
  • the power supply is switched to a pair of probes in area 2 such that the area residing between these probes is subject to the waveform 37 .
  • This process is reversed for period 38 and again for period 40 .
  • Subsequent switching of power back and forth between probe sets treating two separate areas enables each area to receive a waveform as depicted in FIG. 8A substantially simultaneously.
  • probes 46 , 48 , 50 and 52 are attached to one treatment area of a subject and probes 54 , 56 , 58 and 60 are attached to another separate treatment area.
  • electrical current is caused to flow between probes 46 and 50 in treatment area 1 whilst treatment area 2 is not treated.
  • the power supply is switched to provide a positive first half of a cycle between probes 54 and 60 in treatment area 2 . This process continues for the remainder of the treatment with the electrical current being switched between the individual probe sets in treatment areas 1 and 2 .
  • both areas will have been treated simultaneously.
  • probes 62 , 64 , 66 and 68 are attached to one side of a treatment area of a subject and probes 70 , 72 , 74 and 76 are attached to the other side.
  • electrical current is caused to flow between probes 62 and 66 on one side of the treatment area whilst the other side is not treated.
  • the power supply is switched to provide a positive first half of a cycle between probes 70 and 74 . This process continues for the remainder of the treatment with the electrical current being switched between the individual probe sets in different sections of the treatment area.
  • the treatment area will have been treated far more intensively or allowed the reduction of the necessary treatment time.
  • the ability to apply signals to the output of one multiplexer and provide a return current path via another multiplexer and the control of the multiplexer signal lines enables the apparatus to be configured such that the power supply signal supplied from a current regulator circuit bypasses the skin tissue of a subject such that the electrical signal is supplied directly back to the current regulator circuit. In this instance, current flow is through the apparatus itself and this configuration may be used as a test to calibrate the current controlled by the current regulation circuit.
  • FIG. 5 a circuit diagram is shown detailing a conventional power supply arrangement which is used to supply power to the devices detailed in FIGS. 1 to 4 .
  • the improved apparatus and method of the present invention enables the establishment of complex current paths through an area under treatment. Further, application of this type of treatment with an apparatus of the present invention ensures that an area under treatment receives a significantly more uniform treatment as compared with prior systems that rely primarily upon the skill of an operator with respect to the placement of pads.
  • the ability of the apparatus of the present invention to treat separate areas simultaneously with a single power supply by using the “off” period of a waveform in one area to supply electrical current to another area significantly improves the efficiency of the application of treatments.
  • an apparatus according to the present invention is achieved without significantly increasing the number of power supplies contained within the apparatus.
  • an electro stimulation system according to the present invention may be manufactured within an acceptable cost such that the device is considered affordable for purchase and home use by consumers.
  • An improved apparatus and method according to the present invention further enhances medical aspects of this type of treatment including the healing of wounds, decubitus, fractures etc by activating circulation and the tissue activity. It is also possible that an apparatus and method according to the present invention may be used to assist the process of generating or growing tissue and/or cells for skin grafts or other tissue replacement therapies or other purposes. This aspect is particularly beneficial in relation to the treatment of burn victims or any other patients suffering the effect of the removal of skin tissue.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Electrotherapy Devices (AREA)
  • Surgical Instruments (AREA)
  • Neurology (AREA)
US10/734,925 2002-12-12 2003-12-12 Electro stimulation treatment apparatus and method Abandoned US20040147978A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/565,849 US9572978B2 (en) 2002-12-12 2012-08-03 Electro stimulation treatment apparatus and method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002953278A AU2002953278A0 (en) 2002-12-12 2002-12-12 Electro stimulation treatment apparatus and method
AU21002953278 2002-12-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/565,849 Continuation US9572978B2 (en) 2002-12-12 2012-08-03 Electro stimulation treatment apparatus and method

Publications (1)

Publication Number Publication Date
US20040147978A1 true US20040147978A1 (en) 2004-07-29

Family

ID=30004363

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/734,925 Abandoned US20040147978A1 (en) 2002-12-12 2003-12-12 Electro stimulation treatment apparatus and method
US13/565,849 Expired - Fee Related US9572978B2 (en) 2002-12-12 2012-08-03 Electro stimulation treatment apparatus and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/565,849 Expired - Fee Related US9572978B2 (en) 2002-12-12 2012-08-03 Electro stimulation treatment apparatus and method

Country Status (8)

Country Link
US (2) US20040147978A1 (zh)
EP (1) EP1575660A1 (zh)
JP (2) JP2006509542A (zh)
CN (1) CN1738661B (zh)
AU (1) AU2002953278A0 (zh)
CA (1) CA2549407A1 (zh)
SG (1) SG166000A1 (zh)
WO (1) WO2004052446A1 (zh)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060229687A1 (en) * 2005-04-11 2006-10-12 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
WO2006110690A1 (en) * 2005-04-11 2006-10-19 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US20080183251A1 (en) * 2006-07-27 2008-07-31 Zion Azar Apparatus and method for non-invasive treatment of skin tissue
US7519431B2 (en) 2005-04-11 2009-04-14 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
WO2009134477A1 (en) * 2008-04-29 2009-11-05 Medtronic, Inc. Therapy program modification
CN108619615A (zh) * 2017-03-16 2018-10-09 天津市舒沥通医疗器械科技有限公司 一种新型电化学前列腺增生治疗仪

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9937342B2 (en) 2007-04-30 2018-04-10 Medtronic, Inc. Shifting of electrical stimulation electrode combinations among differently sized electrode arrays
JP6352921B2 (ja) * 2012-09-10 2018-07-04 ダーマル フォトニクス コーポレイション 皮膚科医療装置、皮膚科医療システムおよび使用回数制電子補充の方法
ES2720802T3 (es) 2013-01-21 2019-07-24 Cala Health Inc Dispositivos para controlar temblores
JP6606105B2 (ja) 2014-06-02 2019-11-13 カラ ヘルス，インコーポレイテッド 振戦を治療するための抹消神経刺激用のシステム及び方法
CN112914514A (zh) 2015-06-10 2021-06-08 卡拉健康公司 用于外周神经刺激以利用可拆卸治疗和监测单元治疗震颤的系统和方法
EP3352843B1 (en) 2015-09-23 2021-06-23 Cala Health, Inc. Device for peripheral nerve stimulation in the finger to treat hand tremors
AU2017211048B2 (en) 2016-01-21 2022-03-10 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
JP7077297B2 (ja) 2016-07-08 2022-05-30 カラ ヘルス，インコーポレイテッド 厳密にｎ個の電極および改善された乾式電極を用いてｎ個の神経を刺激するためのシステムおよび方法
EP3606604A4 (en) 2017-04-03 2020-12-16 Cala Health, Inc. PERIPHERAL NEUROMODULATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH BLADDER HYPERACTIVITY
CO2017011756A1 (es) 2017-11-17 2019-05-21 Panacea Quantum Leap Tech Llc Dispositivo de estimulación eléctrica y magnética de tejidos
WO2019143790A1 (en) 2018-01-17 2019-07-25 Cala Health, Inc. Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
US11890468B1 (en) 2019-10-03 2024-02-06 Cala Health, Inc. Neurostimulation systems with event pattern detection and classification
CN112642055A (zh) * 2019-10-11 2021-04-13 北京富纳特创新科技有限公司 面膜式美容仪
CN112642051A (zh) * 2019-10-11 2021-04-13 北京富纳特创新科技有限公司 面膜式美容仪

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390023A (en) * 1981-04-30 1983-06-28 Medtronic, Inc. Patterned electrical tissue stimulator
US4996987A (en) * 1989-05-10 1991-03-05 Therapeutic Technologies Inc. Power muscle stimulator
US5063929A (en) * 1989-08-25 1991-11-12 Staodyn, Inc. Electronic stimulating device having timed treatment of varying intensity and method therefor
US5514165A (en) * 1993-12-23 1996-05-07 Jace Systems, Inc. Combined high voltage pulsed current and neuromuscular stimulation electrotherapy device
US5895416A (en) * 1997-03-12 1999-04-20 Medtronic, Inc. Method and apparatus for controlling and steering an electric field
US6516227B1 (en) * 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6631296B1 (en) * 2000-03-17 2003-10-07 Advanced Bionics Corporation Voltage converter for implantable microstimulator using RF-powering coil

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279468A (en) * 1963-05-14 1966-10-18 Vine Sidney Le Electrotherapeutic facial mask apparatus
US3610250A (en) * 1967-01-10 1971-10-05 Robert I Sarbacher Electrical contact-carrying garment for muscle stimulation
US4632117A (en) * 1982-08-09 1986-12-30 Staodynamics, Inc. Simplified transcutaneous nerve stimulating device
US4969468A (en) * 1986-06-17 1990-11-13 Alfred E. Mann Foundation For Scientific Research Electrode array for use in connection with a living body and method of manufacture
US5052391A (en) * 1990-10-22 1991-10-01 R.F.P., Inc. High frequency high intensity transcutaneous electrical nerve stimulator and method of treatment
US5527357A (en) * 1994-06-24 1996-06-18 Springer, Jr.; George E. Apparatus for toning facial tissue
JP2917270B2 (ja) * 1995-08-04 1999-07-12 東洋産業株式会社 低周波治療器
US6413255B1 (en) * 1999-03-09 2002-07-02 Thermage, Inc. Apparatus and method for treatment of tissue
RU2089239C1 (ru) * 1996-02-27 1997-09-10 Владимир Николаевич Дирин Биологический электростимулятор внутренних органов (варианты)
JPH1199190A (ja) * 1997-09-26 1999-04-13 Matsushita Electric Works Ltd 眼精疲労回復装置
JPH11169381A (ja) * 1997-12-15 1999-06-29 Olympus Optical Co Ltd 高周波処置具
BR0007809B8 (pt) * 1999-01-11 2021-06-22 Bmr Res & Development Limited dispositivo de eletroterapia.
JP2000237331A (ja) * 1999-02-16 2000-09-05 Ya Man Ltd パルス美容器
KR20010110754A (ko) * 1999-04-13 2001-12-13 나까도미 히로다카 이온토포레시스 디바이스
US7103398B2 (en) * 2000-11-01 2006-09-05 3M Innovative Properties Company Electrical sensing and/or signal application device
IES20010651A2 (en) * 2001-07-12 2003-01-22 Bmr Res & Dev Ltd A method and apparatus for applying electrical stimulation to a human or animal subject

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390023A (en) * 1981-04-30 1983-06-28 Medtronic, Inc. Patterned electrical tissue stimulator
US4996987A (en) * 1989-05-10 1991-03-05 Therapeutic Technologies Inc. Power muscle stimulator
US5063929A (en) * 1989-08-25 1991-11-12 Staodyn, Inc. Electronic stimulating device having timed treatment of varying intensity and method therefor
US5514165A (en) * 1993-12-23 1996-05-07 Jace Systems, Inc. Combined high voltage pulsed current and neuromuscular stimulation electrotherapy device
US5895416A (en) * 1997-03-12 1999-04-20 Medtronic, Inc. Method and apparatus for controlling and steering an electric field
US6516227B1 (en) * 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6631296B1 (en) * 2000-03-17 2003-10-07 Advanced Bionics Corporation Voltage converter for implantable microstimulator using RF-powering coil

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7957814B2 (en) 2005-04-11 2011-06-07 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US20060229687A1 (en) * 2005-04-11 2006-10-12 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
WO2006110206A1 (en) * 2005-04-11 2006-10-19 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US8751007B2 (en) 2005-04-11 2014-06-10 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
EP2039391A1 (en) * 2005-04-11 2009-03-25 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US7519431B2 (en) 2005-04-11 2009-04-14 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
WO2006110690A1 (en) * 2005-04-11 2006-10-19 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US9259587B2 (en) 2005-04-11 2016-02-16 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US20090234422A1 (en) * 2005-04-11 2009-09-17 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US8738145B2 (en) 2005-04-11 2014-05-27 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US7974703B2 (en) 2005-04-11 2011-07-05 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US20110230940A1 (en) * 2005-04-11 2011-09-22 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US20080183251A1 (en) * 2006-07-27 2008-07-31 Zion Azar Apparatus and method for non-invasive treatment of skin tissue
AU2007278023B2 (en) * 2006-07-27 2013-10-10 Pollogen Ltd Apparatus and method for non-invasive treatment of skin tissue
US8700176B2 (en) * 2006-07-27 2014-04-15 Pollogen Ltd. Apparatus and method for non-invasive treatment of skin tissue
US20110046697A1 (en) * 2008-04-29 2011-02-24 Medtronic, Inc, Therapy program modification
US8554331B2 (en) 2008-04-29 2013-10-08 Medtronic, Inc. Therapy program modification
WO2009134477A1 (en) * 2008-04-29 2009-11-05 Medtronic, Inc. Therapy program modification
CN108619615A (zh) * 2017-03-16 2018-10-09 天津市舒沥通医疗器械科技有限公司 一种新型电化学前列腺增生治疗仪

Also Published As

Publication number Publication date
CN1738661A (zh) 2006-02-22
JP2011183230A (ja) 2011-09-22
EP1575660A1 (en) 2005-09-21
US20130066388A1 (en) 2013-03-14
AU2002953278A0 (en) 2003-01-02
CA2549407A1 (en) 2004-06-24
JP2006509542A (ja) 2006-03-23
US9572978B2 (en) 2017-02-21
WO2004052446A1 (en) 2004-06-24
SG166000A1 (en) 2010-11-29
CN1738661B (zh) 2013-01-09

Similar Documents

Publication Publication Date Title
US9572978B2 (en) Electro stimulation treatment apparatus and method
RU2522850C2 (ru) Система неинвазивной нейростимуляции
US6564103B2 (en) Electrical stimulator and method of use
US20130060304A1 (en) Method and Apparatus for Generating Electrotherapeutic or Electrodiagnostic Waveforms
KR100734212B1 (ko) 전자 치료 장치, 피드백 제어 장치, 전극 및 프로그램을 기록한 컴퓨터로 읽을 수 있는 기록매체
EP2340079B1 (en) Microcurrent and cranial electrotherapy stimulator for control of anxiety, insomnia depression and pain
US9008793B1 (en) Multiple electrode radiofrequency generator
EP0111229A2 (en) Electric nerve stimulator device
US11071862B2 (en) Noninvasive deep brain stimulation system having k focuses
JP2002113115A (ja) バリアント方式を利用した電気治療装置
KR950014481B1 (ko) 전기자극 장치
KR20230056676A (ko) 알츠하이머 및 치매에 대한 tacs(transcranial alternating current dynamic frequency stimulation) 시스템 및 방법
AU2003294151B2 (en) Electro stimulation treatment apparatus and method
EP4048372A1 (en) Method and apparatus for controlling multi-site neurostimulation
Rieger et al. A device for emulating cuff recordings of action potentials propagating along peripheral nerves
WO2021186416A1 (en) Systems, devices and methods for anxiety treatment using vestibular nerve stimulation
KR20200099953A (ko) 전기 자극 장치
CN115671549B (zh) 一种低功耗的电刺激方法及装置
JP3159214U (ja) プローブ装置
WO2022214196A1 (en) Medical device and method for operating a medical device
KR20220050836A (ko) 전정 신경 자극을 이용하는 수면 치료 장치
KR20240126526A (ko) 측정 및 치료 기기와 그 동작 방법
CN116139402A (zh) 便携式电刺激装置、移动终端以及电刺激治疗系统
CN118846382A (zh) 多通道的经颅电刺激装置及系统
KR20210029492A (ko) 정전류 제어 회로를 포함하는 경두개 전기자극 장치

Legal Events

Date Code Title Description
AS Assignment

Owner name: SKOP GMBH LTD, VIRGIN ISLANDS, BRITISH

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BERNHARD, AXEL L.;COOK, ALAN;REEL/FRAME:014800/0705;SIGNING DATES FROM 20031209 TO 20031210

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION